Table 2 Comparison of C. auris infected patients with C. auris colonizers
Variable | Infection (n = 65) | Colonization (n = 27) | p-value |
|---|---|---|---|
Male | 35 (53.8%) | 13 (48.1%) | 0.85 |
Age group | |||
16–35 | 15 (23.1%) | 5 (18.5%) | |
36–55 | 20 (30.8%) | 6 (22.2%) | 0.51 |
56–75 | 21 (32.3%) | 9 (33.3%) | |
76–95 | 9 (13.8%) | 7 (25.9%) | |
ICU | 23 (35.4%) | 7 (25.9%) | 0.12 |
HDU | 24 (36.9%) | 6 (22.2%) | |
Ward | 11 (40.7%) | 16 (24.6%) | |
DM | 18 (27.7%) | 8 (29.6%) | 0.85 |
Malignancy | 13 (20%) | 5 (18.5%) | 0.80 |
Surgery | 39 (60%) | 14 (51.9%) | 0.61 |
Co-infection with MDR bacteria | 22 (33.8%) | 7 (25.9%) | 0.45 |
Appropriate antifungal therapy | 44 (67.7%) | 0 | < 0.001 |
Source control | 40 (61.5%) | 7 (25.9%) | < 0.001 |
Mortality | 30 (46.2%) | 9 (33.3%) | 0.25 |
14-day mortality | 23 (35.4%) | 6 (22.2%) | 0.45 |
Clinical failure | 24 (64.9%) | 6 (22.2%) | < 0.001 |
Alive | 35 (53.8%) | 18 (66.7%) | |
C. auris death | 19 (29.2%) | 0 | |
Non-auris death | 11 (16.9%) | 9 (33.3%) | 0.005 |